Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Thalassaemia2 trials
• Myelodysplastic syndromes1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• Celgene2 trials

Running trials

• Recruiting

  Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

  NCT04143724· Phase 2· Celgene· Source

  Contact: Manuela Balocco, Site 303

• Recruiting

  A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

  NCT04064060· Phase 3· Celgene· Source

  Contact: Manuela Balocco, Site 476

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Thalassaemia2 recruiting
• Myelodysplastic syndromes1 recruiting
• Myeloproliferative neoplasms1 recruiting